Globus Medical
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Globus Medical sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Globus Medical: 10 sponsored US clinical trials, 1 recruiting.
Globus Medical sponsors 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 6 completed. The most-studied condition in this pipeline is Idiopathic Scoliosis, with 1 trials.
Top-decile sponsor footprint
Globus Medical ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
REFLECT Scoliosis System Post Approval Study
NCT06298812
A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis
NCT07589023
Amnios™ RT Outcomes Study
NCT04088383
A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System
NCT02184520
Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOK
NCT01861899
Study of an Expandable Interbody Device for the Lumbar Spine
NCT02075554
INDEPENDENCE Spacer for Lumbar Fusion
NCT02299323
TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study
NCT01198470
Study Evaluating the Safety and Effectiveness of the FLEXUS(TM) Interspinous Spacer
NCT01156675
A Pivotal Study of a Facet Replacement System to Treat Spinal Stenosis
NCT00401518
Therapeutic Areas
What is open in the Globus Medical pipeline
1 recruiting of 10 indexed (10% open); 6 completed (60%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Idiopathic Scoliosis (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Globus Medical: open-pipeline peers nationwide
Peers matched on 10 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Globus Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Abiomed · 10% recruiting · 20 trials
- Aimmune Therapeutics · 10% recruiting · 10 trials
- Altria Client Services · 10% recruiting · 10 trials
- Alzheimer's Disease Cooperative Study (ADCS) · 10% recruiting · 10 trials
Related
What to do with this Globus Medical page
10 registered trials is a research-attention snapshot, not an endorsement of Globus Medical or any single study.
- 1 of Globus Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Idiopathic Scoliosis is the condition Globus Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Idiopathic Scoliosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Globus Medical pipeline card: 10 registered trials from official public datasets.Report a data error.